Skip to content
healthcare.dev
Get a free key

XELJANZ XR

NDC 63539-502, tofacitinib, tablet, extended release, from U.S. Pharmaceuticals.

Product NDC
63539-502
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-502 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE22 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
63539-502-306353905023030 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/68e3d6b2-7838-4d2d-a417-09d919b43e13

Use it

Look up 63539-502 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-502 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.